Skip to main content
NCBI home page
Journal of Virology logoLink to Journal of Virology
. 1985 Jun;54(3):757–763. doi: 10.1128/jvi.54.3.757-763.1985

An avirulent G1 glycoprotein variant of La Crosse bunyavirus with defective fusion function.

F Gonzalez-Scarano, R S Janssen, J A Najjar, N Pobjecky, N Nathanson
PMCID: PMC254862  PMID: 3889368

Abstract

La Crosse virus, a member of the California serogroup of the family Bunyaviridae, causes encephalitis in humans and laboratory rodents. A variant virus (V22) selected with a monoclonal antibody against the large (G1) glycoprotein showed diminished neuroinvasiveness after peripheral inoculation. This variant has an alteration in its fusion function, requiring a lower pH for the activation of fusion and demonstrating reduced efficiency of cell-to-cell fusion of BHK-21 cultures. V22 was studied in detail following the infection by intraperitoneal or intracerebral routes in suckling, weanling, or adult CD-1 mice. It exhibited a marked reduction in its ability to replicate in striated muscle and to produce viremia; however, after intracerebral injection V22 virus replicated almost as rapidly in brain as its parent, La Crosse virus. V22 virus thus represents an example of reduced neuroinvasiveness associated with an alteration at a specific epitope of the G1 glycoprotein. This same epitope also influences the fusion activity of the glycoprotein.

Full text

PDF
757

Images in this article

759Image
on p.759

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Coulon P., Rollin P., Aubert M., Flamand A. Molecular basis of rabies virus virulence. I. Selection of avirulent mutants of the CVS strain with anti-G monoclonal antibodies. J Gen Virol. 1982 Jul;61(Pt 50):97–100. doi: 10.1099/0022-1317-61-1-97. [DOI] [PubMed] [Google Scholar]
  2. Daniels R. S., Douglas A. R., Skehel J. J., Wiley D. C. Analyses of the antigenicity of influenza haemagglutinin at the pH optimum for virus-mediated membrane fusion. J Gen Virol. 1983 Aug;64(Pt 8):1657–1662. doi: 10.1099/0022-1317-64-8-1657. [DOI] [PubMed] [Google Scholar]
  3. Dietzschold B., Wunner W. H., Wiktor T. J., Lopes A. D., Lafon M., Smith C. L., Koprowski H. Characterization of an antigenic determinant of the glycoprotein that correlates with pathogenicity of rabies virus. Proc Natl Acad Sci U S A. 1983 Jan;80(1):70–74. doi: 10.1073/pnas.80.1.70. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Eshita Y., Bishop D. H. The complete sequence of the M RNA of snowshoe hare bunyavirus reveals the presence of internal hydrophobic domains in the viral glycoprotein. Virology. 1984 Sep;137(2):227–240. doi: 10.1016/0042-6822(84)90215-0. [DOI] [PubMed] [Google Scholar]
  5. Fan D. P., Sefton B. M. The entry into host cells of Sindbis virus, vesicular stomatitis virus and Sendai virus. Cell. 1978 Nov;15(3):985–992. doi: 10.1016/0092-8674(78)90282-9. [DOI] [PubMed] [Google Scholar]
  6. Gentsch J. R., Bishop D. L. M viral RNA segment of bunyaviruses codes for two glycoproteins, G1 and G2. J Virol. 1979 Jun;30(3):767–770. doi: 10.1128/jvi.30.3.767-770.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Gething M. J., White J. M., Waterfield M. D. Purification of the fusion protein of Sendai virus: analysis of the NH2-terminal sequence generated during precursor activation. Proc Natl Acad Sci U S A. 1978 Jun;75(6):2737–2740. doi: 10.1073/pnas.75.6.2737. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gonzalez-Scarano F. La Crosse virus G1 glycoprotein undergoes a conformational change at the pH of fusion. Virology. 1985 Jan 30;140(2):209–216. doi: 10.1016/0042-6822(85)90359-9. [DOI] [PubMed] [Google Scholar]
  9. Gonzalez-Scarano F., Pobjecky N., Nathanson N. La Crosse bunyavirus can mediate pH-dependent fusion from without. Virology. 1984 Jan 15;132(1):222–225. doi: 10.1016/0042-6822(84)90107-7. [DOI] [PubMed] [Google Scholar]
  10. Gonzalez-Scarano F., Shope R. E., Calisher C. E., Nathanson N. Characterization of monoclonal antibodies against the G1 and N proteins of LaCrosse and Tahyna, two California serogroup bunyaviruses. Virology. 1982 Jul 15;120(1):42–53. doi: 10.1016/0042-6822(82)90005-8. [DOI] [PubMed] [Google Scholar]
  11. Grady L. J., Srihongse S., Grayson M. A., Deibel R. Monoclonal antibodies against La Crosse virus. J Gen Virol. 1983 Aug;64(Pt 8):1699–1704. doi: 10.1099/0022-1317-64-8-1699. [DOI] [PubMed] [Google Scholar]
  12. Helenius A., Marsh M. Endocytosis of enveloped animal viruses. Ciba Found Symp. 1982;(92):59–76. doi: 10.1002/9780470720745.ch4. [DOI] [PubMed] [Google Scholar]
  13. Hsu M., Scheid A., Choppin P. W. Activation of the Sendai virus fusion protein (f) involves a conformational change with exposure of a new hydrophobic region. J Biol Chem. 1981 Apr 10;256(7):3557–3563. [PubMed] [Google Scholar]
  14. Huang R. T., Rott R., Klenk H. D. Influenza viruses cause hemolysis and fusion of cells. Virology. 1981 Apr 15;110(1):243–247. doi: 10.1016/0042-6822(81)90030-1. [DOI] [PubMed] [Google Scholar]
  15. Janssen R., Gonzalez-Scarano F., Nathanson N. Mechanisms of bunyavirus virulence. Comparative pathogenesis of a virulent strain of La Crosse and an avirulent strain of Tahyna virus. Lab Invest. 1984 Apr;50(4):447–455. [PubMed] [Google Scholar]
  16. Kearney J. F., Radbruch A., Liesegang B., Rajewsky K. A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines. J Immunol. 1979 Oct;123(4):1548–1550. [PubMed] [Google Scholar]
  17. Kingsford L., Ishizawa L. D., Hill D. W. Biological activities of monoclonal antibodies reactive with antigenic sites mapped on the G1 glycoprotein of La Crosse virus. Virology. 1983 Sep;129(2):443–455. doi: 10.1016/0042-6822(83)90182-4. [DOI] [PubMed] [Google Scholar]
  18. Köhler G., Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 1975 Aug 7;256(5517):495–497. doi: 10.1038/256495a0. [DOI] [PubMed] [Google Scholar]
  19. Lenard J., Miller D. K. Uncoating of enveloped viruses. Cell. 1982 Jan;28(1):5–6. doi: 10.1016/0092-8674(82)90368-3. [DOI] [PubMed] [Google Scholar]
  20. Mann E., Edwards J., Brown D. T. Polycaryocyte formation mediated by Sindbis virus glycoproteins. J Virol. 1983 Mar;45(3):1083–1089. doi: 10.1128/jvi.45.3.1083-1089.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Marsh M., Helenius A. Adsorptive endocytosis of Semliki Forest virus. J Mol Biol. 1980 Sep 25;142(3):439–454. doi: 10.1016/0022-2836(80)90281-8. [DOI] [PubMed] [Google Scholar]
  22. Matlin K. S., Reggio H., Helenius A., Simons K. Pathway of vesicular stomatitis virus entry leading to infection. J Mol Biol. 1982 Apr 15;156(3):609–631. doi: 10.1016/0022-2836(82)90269-8. [DOI] [PubMed] [Google Scholar]
  23. McCarthy M., Jubelt B., Fay D. B., Johnson R. T. Comparative studies of five strains of mumps virus in vitro and in neonatal hamsters: evaluation of growth, cytopathogenicity, and neurovirulence. J Med Virol. 1980;5(1):1–15. doi: 10.1002/jmv.1890050102. [DOI] [PubMed] [Google Scholar]
  24. Obijeski J. F., Bishop D. H., Murphy F. A., Palmer E. L. Structural proteins of La Crosse virus. J Virol. 1976 Sep;19(3):985–997. doi: 10.1128/jvi.19.3.985-997.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Scheid A., Choppin P. W. Two disulfide-linked polypeptide chains constitute the active F protein of paramyxoviruses. Virology. 1977 Jul 1;80(1):54–66. doi: 10.1016/0042-6822(77)90380-4. [DOI] [PubMed] [Google Scholar]
  26. Shope R. E., Rozhon E. J., Bishop D. H. Role of the middle-sized bunyavirus RNA segment in mouse virulence. Virology. 1981 Oct 15;114(1):273–276. doi: 10.1016/0042-6822(81)90276-2. [DOI] [PubMed] [Google Scholar]
  27. Skehel J. J., Bayley P. M., Brown E. B., Martin S. R., Waterfield M. D., White J. M., Wilson I. A., Wiley D. C. Changes in the conformation of influenza virus hemagglutinin at the pH optimum of virus-mediated membrane fusion. Proc Natl Acad Sci U S A. 1982 Feb;79(4):968–972. doi: 10.1073/pnas.79.4.968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Spriggs D. R., Bronson R. T., Fields B. N. Hemagglutinin variants of reovirus type 3 have altered central nervous system tropism. Science. 1983 Apr 29;220(4596):505–507. doi: 10.1126/science.6301010. [DOI] [PubMed] [Google Scholar]
  29. Spriggs D. R., Fields B. N. Attenuated reovirus type 3 strains generated by selection of haemagglutinin antigenic variants. Nature. 1982 May 6;297(5861):68–70. doi: 10.1038/297068a0. [DOI] [PubMed] [Google Scholar]
  30. White J., Matlin K., Helenius A. Cell fusion by Semliki Forest, influenza, and vesicular stomatitis viruses. J Cell Biol. 1981 Jun;89(3):674–679. doi: 10.1083/jcb.89.3.674. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Wiktor T. J., Koprowski H. Antigenic variants of rabies virus. J Exp Med. 1980 Jul 1;152(1):99–112. doi: 10.1084/jem.152.1.99. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Wolinsky J. S., Stroop W. G. Virulence and persistence of three prototype strains of mumps virus in newborn hamsters. Arch Virol. 1978;57(4):355–359. doi: 10.1007/BF01320075. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES